Skip to content

Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer

Feasibility of an Evidence-based Walking Program in a Sample of Men Age >65 Undergoing Treatment for Prostate Cancer

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02139774
Enrollment
15
Registered
2014-05-15
Start date
2013-10-31
Completion date
2014-06-30
Last updated
2015-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate Cancer, Elderly, Geriatric, Radiation, Arthritis, Exercise, Walking, Endocrine Therapy, Androgen Deprivation Therapy, Active Surveillance, Men

Brief summary

This study is testing a walking program called Walk with Ease by the Arthritis Foundation with men undergoing treatment for prostate cancer. The researchers are interested in how easy or difficult it is for these men to participate in this program and whether or not is is helpful to them during their care.

Detailed description

Purpose: This pilot study evaluates the feasibility of implementing a moderate-intensity physical activity (PA) program in a sample of men age 65 or older with a prostate cancer diagnosis undergoing various forms of treatment or active surveillance. Participants: Men, 65 and older, with a prostate cancer diagnosis. Procedures (methods): This study will enroll subjects in a 6 week walking program called Walk with Ease (WWE) and see if walking can be sustained for up to three months. In addition, the study will perform a Geriatric Assessment and gather preliminary data on self-reported quality of life outcomes and self-reported physical activity as captured in a daily walking log.

Interventions

BEHAVIORALWalk with Ease

A six week walking program by the Arthritis Foundation

Sponsors

UNC Lineberger Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥65 years of age * Histologically confirmed Stage I, II or III prostate cancer (endocrine (± radiation) patients may be Stage IV) * Undergoing prostate cancer treatment (post-surgery only, radiation only, endocrine therapy (± radiation), or active surveillance) * English speaking * IRB approved, signed written informed consent * Approval from their treating physician to engage in moderate-intensity physical activity * Patient-assessed ability to walk and engage in moderate physical activity * Willing and able to meet all study requirements

Exclusion criteria

* One or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention * Major surgery scheduled within the study period * Unable to walk or engage in moderate-intensity physical activity * Already actively walking (150 minutes per week)

Design outcomes

Primary

MeasureTime frameDescription
To measure the feasibility of implementing the WWE intervention among men age >65 with a prostate cancer diagnosis24 monthsExploring the evaluate the feasibility of implementing the WWE intervention among men age \>65 with a prostate cancer diagnosis. The study will measure those who were able to complete the program and increased their self-reported level of walking. The study will also measure the percent of patients who reach the goal of walking 30 minutes a day for 5 days a week in order to determine feasibility.

Secondary

MeasureTime frameDescription
Measure the rate of completion for study surveys24 monthsTo evaluate the rate of completion of each of the following measures/assessments at 3 different time points -- baseline, 6 weeks (end of WWE intervention), and 3 months (follow-up): * Self-reported walking log * Functional Assessment of Cancer Therapy-General (FACT-G)25 * Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue26 * Outcome Expectations for Exercise (OEE) scale27 * Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM)28,29 * Visual Analog Scales (VAS) for Pain, Fatigue and Stiffness30-32 * PROMIS Pain Interference Short Form 6b33-35 * BRFSS Questionnaire 2011 -Health Behaviors Questionnaire (HBQ)36 * Geriatric Assessment (GA) (Version 5)

Other

MeasureTime frameDescription
Use primary data to design future studies36 monthsTo explore data from the measures/assessments (summary measures at each time point and mean changes at 6 weeks and 3 months) to inform future studies designed to evaluate associations between the WWE program and these variables.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026